Brief: Galectin Therapeutics Announces 2 Liver Cirrhosis Scientific Presentations At The Easl International Liver Congress 2022
21/06/2022 14:52
June 21 (Reuters) - Galectin Therapeutics Inc GALT.O :
* GALECTIN THERAPEUTICS ANNOUNCES 2 LIVER CIRRHOSIS
SCIENTIFIC
PRESENTATIONS AT THE EASL INTERNATIONAL LIVER CONGRESS™ 2022
Source text for Eikon: ID:nGNX5JDcwV
Further company coverage: GALT.O
Recent news on Galectin Therapeutics
See all newsGalectin Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Galectin Therapeutics Reports June 30, 2026 Financial Results
Galectin Therapeutics Q2 loss widens
Galectin Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Galectin Therapeutics rises as FDA clears path for late-stage liver drug study